1. Home
  2. COCP vs BCG Comparison

COCP vs BCG Comparison

Compare COCP & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

BUY

Current Price

$1.11

Market Cap

21.6M

Sector

Health Care

ML Signal

BUY

BCG

Binah Capital Group Inc.

HOLD

Current Price

$1.00

Market Cap

21.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCP
BCG
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
21.6M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
COCP
BCG
Price
$1.11
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 51.5K
22.2K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
54.65
★ 112.50
EPS
N/A
★ 0.08
Revenue
$12,712,091.00
★ $187,144,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$13.13
Revenue Growth
N/A
★ 10.80
52 Week Low
$0.76
$1.03
52 Week High
$2.03
$3.44

Technical Indicators

Market Signals
Indicator
COCP
BCG
Relative Strength Index (RSI) 39.79 21.49
Support Level $0.99 N/A
Resistance Level $1.12 $1.65
Average True Range (ATR) 0.07 0.05
MACD -0.02 -0.01
Stochastic Oscillator 4.55 10.96

Price Performance

Historical Comparison
COCP
BCG

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About BCG Binah Capital Group Inc.

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: